Gilead Sciences
GILD
#136
Rank
A$225.22 B
Marketcap
A$181.40
Share price
0.09%
Change (1 day)
10.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): A$10.43

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A$9.93. In 2024 the company made an earnings per share (EPS) of A$0.55 a decrease over its 2023 EPS that were of A$6.59.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$10.431794.53%
2024A$0.55-91.65%
2023A$6.5923.98%
2022A$5.32-25.86%
2021A$7.174850%
2020A$0.14-97.64%
2019A$6.150.9%
2018A$6.0918.71%
2017A$5.13-64.88%
2016A$14.61-18.45%
2015A$17.9155.28%
2014A$11.54296.02%
2013A$2.9117.89%
2012A$2.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.66 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.90-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.98-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$40.91 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.99 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$13.55 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.01-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$24.65 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.16-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA